Asacol Dosing Study for Active Ulcerative Colitis

Summary

We, the investigators at University of Washington, plan on evaluating the effect of open label Asacol at a dose of 4.8 grams/day divided BID (twice per day) or TID (three times per day) on its ability to induce remission in patients with mild to moderately active ulcerative colitis. We hypothesize that both regimens will have the same efficacy and no difference in side effects.

Timeline

Start

2003-06

Primary completion

2007-08

Completion

2007-08

Drugs

Indications